Welcome to the 4th European Headache and Migraine Trust International Congress 2014, in Copenhagen, the premier international event for neurologists, physicians, scientists, researchers, and international experts and healthcare professionals with an interest in migraine and headache disorders.

The four day programme continues to build on its basic and clinical science content by covering the latest available research, therapies, and developments from internationally recognised leaders in the field. The aim of this Congress is to provide a better understanding of migraine, tension-type headache, trigeminal autonomic cephalalgias and other headache disorders as well as trigeminal pain worldwide and to give participants the opportunity to gather new scientific evidence and understanding for improving diagnosis and treatment for patients.

Poster presentations are a key feature of EHMTIC2014 and the programme has been planned to allow ample time for poster viewing and chaired discussions with an emphasis on interaction across all sessions. We will feature the best of our developing researchers in the New Scientist lectures, an opportunity to hear what is happening at the absolute cutting edge.

Three Teaching Courses are scheduled prior to the start of the main programme offer focused updates for primary care practitioners and others with special interest in the field of headache; an educational case-based interactive session aimed at clinical staff to update their knowledge and learn about new therapies; and a course aimed at trainees interested in novel techniques and developments in migraine research.

We will finish with a public session for patients with migraine and headache disorders, providing an overview of the Congress presentations.

The sponsored satellite symposia are also an important part of the programme and we encourage you to attend these sessions to learn about the latest developments from our healthcare industry partners.

On behalf of the International Scientific Advisory Committee, we would like to express our grateful thanks to the exhibitors and generous sponsors of the Congress, the EHMTIC Board, The Migraine Trust, EHF Board, the abstract reviewers, session chairs, the presenters who are sharing their research and experience with us and to our delegates who continue to support the Congress.

Please take every opportunity within the Congress to learn, familiarise yourself with new ideas and hear about the latest study results. Share your knowledge with others, build new friendships and meet old acquaintances. We also hope you find time to enjoy the wonderful city of Copenhagen.

Yours sincerely,

Peter J. Goadsby MD PhD DSc Trustee, The Migraine Trust

Rigmor Højland JensenMD, Dr.Med. Sci, Professor President of EHF

Submission Info

Abstracts must be submitted before the deadline date of Tuesday 29 April 2014

Abstract Guidelines:

1. Abstracts must be submitted via this website. Faxed, posted or emailed abstracts will NOT be accepted.
2. The submitting author MUST be the presenting author.
3. Abstracts must be submitted before midnight of the abstract submission deadline. Abstracts received after this deadline will NOT be accepted.
4. All abstracts will be reviewed by the faculty and successful applicants will be chosen based on originality and clinical applicability of the work.Abstracts will be either accepted for oral presentation, poster display or rejected.
5. The scientific faculty reserves the right to accept or refuse an abstract and to choose a suitable session for the abstract.
6. Work must be original and not have been published or presented in any international meetings previously.
7. The presenting author is required to ensure that all co-authors are aware of the content of the abstract before submission.
8. Abstracts must be typed in English.
9. Inclusion in the Scientific Program and CD of Abstracts is dependent on payment of registration fees
10. Abstract length should not exceed 250 words
11. The presenting author must be registered for at least the first two days of the Congress.

Declaration of Consent to Publication and Assignation of Copyright

• I confirm that I previewed this abstract and that all information is correct. I accept that the content of this abstract cannot be modified or corrected after final submission and I am aware that it will be published exactly as submitted.
• Submission of the abstract constitutes my consent to publication (e.g. congress website, programs, other promotions, etc.)
• The Abstract Submitter warrants and represents that he/she is the sole owner or has the rights of all the information and content (“Content”) provided to EHMTIC 2014 and Kenes UK (Hereafter: “The Organisers”). The publication of the abstract does not infringe any third party rights including, but not limited to, intellectual property rights.
• The Abstract Submitter grants the Organisers a royalty-free, perpetual, irrevocable nonexclusive license to use, reproduce, publish, translate, distribute, and display the Content.
• The Organisers reserve the right to remove from any publication an abstract which does not comply with the above.
  I herewith confirm that the contact details saved in this system are those of the corresponding author, who will be notified about the status of the abstract. The corresponding author is responsible for informing the other authors about the status of the abstract.

The reviewing process will take several weeks, after which you will be notified of your abstract status. After selection, all presenting authors will be sent full details regarding the scheduling of their presentation, including the time and date of the presentation.

For any queries, please contact the Secretariat: ehmtic@kenes.com

1-3, rue de Chantepoulet
P.O. Box 1726
CH-1211 Geneva 1, Switzerland
Tel: +41 22 908 0488
Fax: +41 22 906 9140

E-mail: ehmtic@kenes.com

Website: www.ehmtic2014.com